Sci/Tech Chemotherapy with light; only one injection required: Promises complete elimination of cancer cells without side effects

tom_mai78101

The Helper Connoisseur / Ex-MineCraft Host
Staff member
Reaction score
1,633
Researchers in South Korea have developed a phototherapy technology that can significantly increase efficiency while reducing the pain of chemotherapy and minimizing side effects after treatment. The President of Korea Institute of Science and Technology (KIST), Seok-Jin Yoon announced that a research team led by Dr. Sehoon Kim at the Theragnosis Research Center (KU-KIST Graduate School of Converging Science and Technology) has developed a cancer-targeted phototherapeutic agent that promises complete elimination of cancer cells without side effects. It involves only one injection and repeated phototherapy. This development was made through joint research with Professor Dong June Ahn of Korea University and Professor Yoon-Sik Lee of Seoul National University.

Phototherapy technology, a cancer treatment modality that uses light, injects a photosensitizer that destroys cancer cells in response to a laser, which accumulates in only cancerous tissues. Further, it shoots light to selectively destroy the cancer cells. It has far fewer side effects than radiation therapy or general chemotherapy (that inevitably damage the tissues surrounding the cancer cells), allowing repeated treatment.

Since the effect of the conventional photosensitizers only lasts for one session, photosensitizers have to be administered each time the treatment procedure is repeated. Moreover, the residual photosensitizer after treatment accumulates in the skin or eyes causing side effects due to light; thus, it is recommended to isolate the patient from sunlight and indoor lighting for some time after treatment. Overall, the patients receiving phototreatment have had to suffer from the pain of the repeated injection and the inconvenience of isolation in the dark each time. Recently, photosensitizers with phototherapeutic effects that get activated only in cancer tissues have been developed; however, they are still toxic and have to be injected for every repeated session of treatment.

Dr. Sehoon Kim and his team at KIST used peptides that selectively target cancer tissues and assemble themselves in a specific order to resolve the problems associated with the phototherapy technology. The research team developed a peptide-based photosensitizer that activates phototherapeutic effects only in cancer tissues by using the internalizing RGD peptide (iRGD) that can selectively penetrate and target cancer tissues, and by proper design for the modulation of its reaction to light.

 
Last edited by a moderator:

Varine

And as the moon rises, we shall prepare for war
Reaction score
803
I wonder if this would work on Leukemia where the cancer cells aren't concentrated together.
 

The Helper

Necromancy Power over 9000
Staff member
Reaction score
1,688
One of my lifelong family friends just died of Leukemia or from complications of treatment. I hope we see something from this.
 
General chit-chat
Help Users

      The Helper Discord

      Staff online

      Members online

      Affiliates

      Hive Workshop NUON Dome World Editor Tutorials

      Network Sponsors

      Apex Steel Pipe - Buys and sells Steel Pipe.
      Top